Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

March 24, 2021Open Access

A vaccine targeting mutant IDH1 in newly diagnosed glioma

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

T helper cell clusters in a patient with pseudoprogression were dominated by a single IDH1(R132H)-reactive T cell receptor.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

A vaccine targeting mutant IDH1 in newly diagnosed glioma | Synapse

Cite This Study

Platten et al. (Wed,) studied this question.

synapsesocial.com/papers/6a000029f9e1acab462d68be https://doi.org/https://doi.org/10.1038/s41586-021-03363-z

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data2015 · 3,604 citations
2Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade2016 · 3,107 citations
3The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary2016 · 15,954 citations
4The 2007 WHO Classification of Tumours of the Central Nervous System2007 · 13,943 citations
5A vaccine targeting mutant IDH1 induces antitumour immunity2014 · 699 citations